A Senate bipartisan working group that focuses on the 340B program recently welcomed three new members.
On March 21, Sens. Tim Kaine, D-Va., Markwayne Mullin, R-Okla., and John Hickenlooper, D-Colo., joined the cohort, which also includes Sens. Jerry Moran, R-Kan., Tammy Baldwin, D-Wis., and Shelley Capito, R-W.Va.
In February 2024, the Senate 340B bipartisan working group published a legislative discussion draft on how to enhance 340B program integrity.
The recommendations include defining a 340B “patient,” the eligibility of child sites, preventing duplicate discounts and ensuring equitable treatment. The group also proposed allocating $3 million to conducting audits, investigations, oversight and enforcement activities associated with the 340B program.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
